Continuous Manufacturing has been discussed in pharma for decades, yet adoption remains selective and often misunderstood.
In this webinar, Richard Steiner, PCM Practice Lead, Pharmatech Associates, and Anthony Tantuccio, Fellow (Director), Continuous Tableting,
Technology Intensificationn Hovione, cut through the hype to explore the technical, operational, and regulatory realities of Continuous Manufacturing today.
From the impact of ICH Q13 to hybrid manufacturing models and real-world implementation lessons, the discussion focuses on facts, not buzzwords, helping industry leaders make informed decisions.
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
Pharmatech Associates, Inc. 9110 Alcosta Blvd. STE H #601 San Ramon CA 94583
